4LSA Stock Overview
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Athersys, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.045 |
52 Week High | US$1.73 |
52 Week Low | US$0.041 |
Beta | -0.90 |
1 Month Change | 0% |
3 Month Change | -55.00% |
1 Year Change | -95.91% |
3 Year Change | -99.88% |
5 Year Change | -99.85% |
Change since IPO | -99.90% |
Recent News & Updates
Recent updates
Shareholder Returns
4LSA | DE Biotechs | DE Market | |
---|---|---|---|
7D | 0% | 2.8% | -0.03% |
1Y | -95.9% | 38.7% | 5.5% |
Rentabilidad frente al sector: 4LSA obtuvo unos resultados inferiores a los del sector German Biotechs , que el año pasado arrojó un rendimiento del -23.1%.
Rentabilidad vs. Mercado: 4LSA obtuvo unos resultados inferiores a los del mercado German, que fue del 5.9% el año pasado.
Price Volatility
4LSA volatility | |
---|---|
4LSA Average Weekly Movement | n/a |
Biotechs Industry Average Movement | 5.4% |
Market Average Movement | 4.8% |
10% most volatile stocks in DE Market | 10.1% |
10% least volatile stocks in DE Market | 2.4% |
Precio estable de las acciones: 4LSAha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: Datos insuficientes para determinar el cambio de volatilidad de 4LSA en el último año.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | 24 | n/a | https://www.athersys.com |
Athersys, Inc. Fundamentals Summary
4LSA fundamental statistics | |
---|---|
Market cap | €428.46k |
Earnings (TTM) | -€34.24m |
Revenue (TTM) | €73.04k |
5.9x
P/S Ratio0.0x
P/E RatioIs 4LSA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4LSA income statement (TTM) | |
---|---|
Revenue | US$80.00k |
Cost of Revenue | US$18.78m |
Gross Profit | -US$18.69m |
Other Expenses | US$18.81m |
Earnings | -US$37.51m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.61 |
Gross Margin | -23,368.75% |
Net Profit Margin | -46,883.75% |
Debt/Equity Ratio | -29.6% |
How did 4LSA perform over the long term?
See historical performance and comparison